Inhaled levofloxacin cystic fibrosis

Pulmonary infections caused by Pseudomonas aeruginosa (PA) represent the leading cause of pulmonary morbidity in adults with cystic fibrosis (CF). Conclusions: In patients with cystic fibrosis, inhaled levofloxacin solution has the potential to improve FEV 1 and to reduce the number of bronchopulmonary exacerbations

2024-03-28
    Spironolactone how to take
  1. Inhaled antibiotics, i
  2. , Sindel L
  3. Nevertheless, no lung deposition data on inhaled levofloxacin are yet
  4. They are on phase 1 yet
  5. , Riethmuller J
  6. Loutit 5 Introduction